Area of research
Oncology · Hematology
Research interest
Research interests include Cancer Treatment and Pharmacology, Multiple Myeloma Research and Treatments, Glioma Diagnosis and Treatment, and Peripheral Neuropathies and Disorders.
E-Selectin Orchestrates IL-1β–Dependent Neuroinflammation via NLRP3 in Vincristine-Induced Neuropathy
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis.
Eculizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report.
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment.
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel.
New Approaches Based on Serial-Block Face Electron Microscopy to Investigate the Peripheral Nervous System.
Analysis of an innovative fluid biomarker panel for early prediction of progression independent of relapse activity in multiple sclerosis.
Molecular Characterization of Oxaliplatin-Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations.
CANVAS causing AAGGG repeat expansions cause tissue-specific reduction in RFC1 expression and increase sensitivity to DNA damage
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection.
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy.
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: The role of nerve excitability testing.
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata.
Effect of age on metabolomic changes in a model of paclitaxel-induced peripheral neurotoxicity.
Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
Multiple Sclerosis Progression and Relapse Activity in Children
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.
Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy.
Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy
Self-Reported Assessment of the Socio-Economic Impact of Anticancer Chemotherapy-Related Neurotoxicity.
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity.
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells.
Toxic medications in Charcot-Marie-Tooth patients: A systematic review.
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent.
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy.
Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin.
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: Systematic review and evidence-based recommendations